Effect of Mulligan's Mobilization on Shoulder Joint Range of Motion and Subacromial Space in Paraplegic Patients

February 10, 2025 updated by: Radwa Fayek Hammam, MTI University

Shoulder Joint Range of Motion and Subacromial Space Changes After Mulligan's Mobilization for Paraplegic Patients with Subacromial Impingement: a Randomized Controlled Trial

The aim of the study is to determine the effect of mulligan's mobilization on shoulder range of motion and subacromial joint space in paraplegic patients with subacromial impingement so, thirty patients will be randomly assigned to two groups group (A) and Group (B)

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

30 patients will be randomly assigned to two groups Group (A): will receive Mulligan's mobilization plus steroid injection for rotator cuff tendinopathy Group (B): will receive Steroid injection for rotator cuff tendinopathy only

Outcome measures will be:

  • shoulder joint range of motion will be measured by laser goniometer
  • Subacromial joint space will be measured by 3D ultrasonography

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Cairo, Egypt
        • Modern University for technology and information

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • More than one year after traumatic spinal cord injury
  • The injury is at the second thoracic level or below.
  • No cognitive impairment
  • Relying on manual wheelchair for main movement.

Exclusion Criteria:

  • No frozen shoulder
  • No subluxation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group A
Will receive mulligan's mobilization plus corticosteroid injection for shoulder joint
Other: Mulligan's mobilization
Mulligan mobilization isthe concurrent application of sustained accessory mobilization applied by a therapist and an active physiological movement to end range applied by the patient.
Other: corticosteroid injection for rotator cuff tendinopathy
corticosteroid injection for rotator cuff helps resolving inflammation which occur for paraplegic patients from overuse of the crutches
Sham Comparator: corticosteroid injection for rotator cuff tendinopathy only
patients will receive corticosteroid injection for rotator cuff muscle only which helps in resolving inflammation at the shoulder joint
Other: corticosteroid injection for rotator cuff tendinopathy
corticosteroid injection for rotator cuff helps resolving inflammation which occur for paraplegic patients from overuse of the crutches

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Shoulder joint range of motion
Time Frame: Two months
Shoulder joint ROM ( flexion - abduction- external and internal rotation will be measured by The laser goniometer HALO
Two months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subacromial joint space
Time Frame: Two months
3D Ultrasonography enables the identification of common shoulder pathologies, and it will be utilized to assess the subacromial space as a kinematic indication of the shoulder.
Two months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

MTI University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2024

Primary Completion (Actual)

January 30, 2025

Study Completion (Actual)

February 10, 2025

Study Registration Dates

First Submitted

November 25, 2024

First Submitted That Met QC Criteria

November 25, 2024

First Posted (Actual)

November 29, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 10, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P.T.REC/012/003273

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Paraplegia, Incomplete

Clinical Trials on Mulligan's mobilization

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe